GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Cochlear COH.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

152.00

-2.23%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

19 analysts, 1 Mar 2026. The analysts' own views, not ours.

  • 2Strong buy
  • 7Buy
  • 9Hold
  • 1Sell
  • 0Strong sell

Price targets

Brokers' own targets, 21 Feb 2026. Not our view.

Average target 265.71

Low
212.10
Average
265.71
Median
252.40
High
341.25

Forecasts

Analyst averages for the fiscal years ahead

FY2027FY2028FY2029FY2030FY2031
RevenueA$2.38bnA$2.51bnA$2.69bnA$2.95bnA$2.33bn
Revenue, highestA$2.46bnA$2.62bnA$2.80bnA$3.07bnA$2.43bn
Revenue, lowestA$2.26bnA$2.38bnA$2.54bnA$2.79bnA$2.21bn
Earnings per share5.215.706.417.227.55
Earnings per share, highest5.446.177.077.607.94
Earnings per share, lowest5.045.105.616.737.03
Analysts161615713

Earnings against forecasts

Earnings per share by fiscal quarter

Q2 2026Q4 2025Q2 2025Q4 2024Q2 2024
Forecast3.112.973.143.142.91
Reported2.982.843.132.962.92
Difference-4.2%-4.4%-0.2%-5.6%+0.5%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

5 / 10

Revenue growth 7.5% a year over 10 years. Return on equity 8.5%.

Model fair value

96.31

From earnings 96.31, from revenue 165.77.

Piotroski score

5 / 9

A nine-point test of financial strength, for 30 Jun 2025.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.